Organizations Name: Sloan Kettering (in ,000s) Fin Statement Field 2016 2015 Benefit Expense $458,454 $457,287 Cash & Cash Equivalents $698,872 $422,330 Current Assets $1,671,295 $1,551,944 Current Liabilities $800,605 $724,248 Depreciation and Amortization Expense $263,964 $232,866 Excess of Revenues over Expenses $178,170 $169,169 Interest Expense $48,724 $49,401 Long-term debt $2,544,709 $2,476,950 Long-term Investments $3,140,818 $3,284,853 Marketable Securities $177,868 $242,330 Net Assets $5,730,977 $5,533,963 Net Patient Accounts Receivable $499,284 $613,285 Net Patient Revenues $2,564,674 $2,309,175 Net Receivables $499,284 $613,285 Operating Expense $3,802,192 $3,506,316 Operating Income (also use as net income) $300,498 $174,100 Principal Payments $0 $0 Salary Expense $1,746,943 $1,340,706 Total Assets $9,891,492 $8,040,077 Total Operating Expense $3,802,192 $3,506,316 Total Operating Revenues $3,980,362 $3,675,485 Net Cash from Operating Activities $300,498 $174,100 Net Cash from Investing Activities $116,114 $605,027 Net Cash from Financing Activities $92,158 $506,536

Using the shortened financial statement for Memorial Sloan Kettering Cancer Center (above)

What is the 2016 total cash from these three parts of the cash flow statement.

What is the percentage of net cash from each of the following:

Operating activities:

Investing activities:

Financing activities

Total Cash from Cash Flow Statement: